SEC Comment Letter 0000000000-25-001996 to Replimune Group, Inc. (REPL) (CIK 0001737953) (REPL)
Replimune Group, Inc. (REPL) (CIK 0001737953)
Date: Feb. 20, 2025 · CIK: 0001737953 · Accession: 0000000000-25-001996
AI Filing Summary & Sentiment
File numbers found in text: 001-38596
Letter
February 20, 2025 Emily Hill Chief Financial Officer Replimune Group, Inc. 500 Unicorn Park Drive, Suite 303 Woburn, MA 01801 Re:Replimune Group, Inc. Form 10-K for Fiscal Year Ended March 31, 2024 File No. 001-38596 Dear Emily Hill: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
February 20, 2025
Emily Hill
Chief Financial Officer
Replimune Group, Inc.
500 Unicorn Park Drive, Suite 303
Woburn, MA 01801
Re:Replimune Group, Inc.
Form 10-K for Fiscal Year Ended March 31, 2024
File No. 001-38596
Dear Emily Hill:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences